Friederike Twele Selected Research

2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)

1/2017	A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy.
8/2015	The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Friederike Twele Research Topics

Disease

12	Seizures (Absence Seizure) 01/2021 - 11/2013
11	Epilepsy (Aura) 01/2021 - 11/2013
7	Temporal Lobe Epilepsy 01/2021 - 08/2015
6	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020 - 08/2015
2	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 08/2015
1	Infections 01/2022
1	Noncommunicable Diseases 08/2021
1	COVID-19 07/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Ototoxicity 01/2016
1	Brain Diseases (Brain Disorder) 02/2014

Drug/Important Bio-Agent (IBA)

10	Kainic Acid (Kainate)IBA 01/2021 - 08/2015
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
3	Drug CombinationsIBA 01/2021 - 01/2019
3	Anticonvulsants (Antiepileptic Drugs)IBA 04/2016 - 02/2014
2	Volatile Organic CompoundsIBA 01/2022 - 07/2020
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2016
2	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 01/2017 - 08/2015
2	AMPA Receptors (AMPA Receptor)IBA 01/2017 - 08/2015
2	Sodium-Potassium-Chloride SymportersIBA 01/2016 - 02/2014
2	Bumetanide (Bumex)FDA LinkGeneric 01/2016 - 02/2014
1	Explosive Agents (Explosives)IBA 08/2021
1	Propiolactone FDA Link 07/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	PQR530IBA 01/2020
1	pqr620IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Topiramate (Topamax)FDA LinkGeneric 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	citrate-binding transport proteinIBA 01/2020
1	Citric Acid (Citrate)FDA LinkGeneric 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Neuroprotective AgentsIBA 01/2019
1	Excitatory Amino Acid AntagonistsIBA 01/2017
1	N-Methylaspartate (NMDA)IBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	ifenprodilIBA 01/2017
1	Pilocarpine (Ocusert)FDA LinkGeneric 04/2016
1	Pentylenetetrazole (Metrazol)IBA 04/2016
1	Isoflurane FDA LinkGeneric 02/2016
1	Chloral HydrateIBA 02/2016
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	ChloridesIBA 01/2016
1	Excitatory Amino Acid AgonistsIBA 01/2016
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 08/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2015
1	Phenytoin (Dilantin)FDA LinkGeneric 08/2015
1	perampanelIBA 08/2015
1	DiureticsIBA 02/2014
1	AWD 131-138IBA 11/2013

Therapy/Procedure

4	Therapeutics 01/2020 - 08/2015
1	Operative Surgical Procedures 01/2017
1	Anesthesia 02/2016